Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center
- 30 April 2008
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 26 (2) , 125-132
- https://doi.org/10.1016/j.urolonc.2007.01.016
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Statin Drugs and Risk of Advanced Prostate CancerJNCI Journal of the National Cancer Institute, 2006
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Diet and cancer preventionOncogene, 2004
- Residential sunlight exposure is associated with a decreased risk of prostate cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Inorganic Selenium Retards Progression of Experimental Hormone Refractory Prostate CancerJournal of Urology, 2004
- Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Selective Inhibitors for Prostate Cancer ChemopreventionJournal of Urology, 2004
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- The Prostate Cancer Prevention Trial: design, status, and promiseWorld Journal of Urology, 2003
- Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study GroupJAMA, 1996
- The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male SmokersNew England Journal of Medicine, 1994